BCA

Overview

BCA (Disodium bicinchoninate) is an orally active and non-competitive Beta-site amyloid precursor protein cleaving enzyme 1 ( BACE1 ) inhibitor with an IC 50 value of 28 µM, a K i value of 43 µM. BCA shows anticancer activity. BCA has the potential for the research of Alzheimer's disease (AD).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > Beta-secretase

Product Information

• Catalog No.: HY-15908
• CAS No.: 979-88-4
• Molecular Formula: C20H10N2Na2O4
• Molecular Weight: 388.28
• Purity: 99.99%
• Storage: 4°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Solubility: 25 mg/mL (64.39 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source